Wanli Jiang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
- Aortic Disease and Treatment Approaches
Papers in
-
- Extracellular vesicles in disease 3
- Surgery 10
- Esophageal and GI Pathology 2
- Co-authors
- Hongbing Wu (7 shared papers)Zhiwei Wang (10 shared papers)Nitao Cheng (1 shared paper)Jiakuan Chen (1 shared paper)Ming Mao (1 shared paper)Jinping Zhao (1 shared paper)Zheng Tang (2 shared papers)Ganjun Kang (7 shared papers)
- Journals
- Annals of Vascular Surgery (3 papers)Current Problems in Cardiology (3 papers)Cell Research (2 papers)International Immunopharmacology (2 papers)Clinica Chimica Acta (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wanli Jiang
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 209
- Pulmonary and Respiratory Medicine 304
- Molecular Biology 438
- Infectious Diseases 90
- Immunology 92
Countries citing papers authored by Wanli Jiang
This map shows the geographic impact of Wanli Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanli Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanli Jiang more than expected).
Fields of papers citing papers by Wanli Jiang
This network shows the impact of papers produced by Wanli Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanli Jiang. The network helps show where Wanli Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanli Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 130 | |
| 2 | 2022 | 102 | |
| 3 | 2020 | 65 | |
| 4 | 2022 | 64 | |
| 5 | 2016 | 62 | |
| 6 | 2004 | 53 | |
| 7 | 2014 | 52 | |
| 8 | 2019 | 31 | |
| 9 | 2019 | 30 | |
| 10 | 2020 | 30 | |
| 11 | 2017 | 29 | |
| 12 | 2014 | 27 | |
| 13 | 2019 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2001 | 26 | |
| 16 | 2017 | 23 | |
| 17 | 2020 | 21 | |
| 18 | 2018 | 21 | |
| 19 | 2013 | 20 | |
| 20 | 2020 | 17 |
About Wanli Jiang
Wanli Jiang is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Infectious Diseases and Oncology, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Extracellular vesicles in disease (3 papers), COVID-19 Impact on Reproduction (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Esophageal and GI Pathology (2 papers). The work is most often cited by research in Cancer Research (209 citations), Pulmonary and Respiratory Medicine (304 citations), Molecular Biology (438 citations), Infectious Diseases (90 citations) and Immunology (92 citations). Wanli Jiang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Hongbing Wu, Zhiwei Wang, Nitao Cheng, Jiakuan Chen, Ming Mao, Jinping Zhao, Zheng Tang, Ganjun Kang, Songping Xie and Zhipeng Hu. Their work appears in journals such as Annals of Vascular Surgery, Current Problems in Cardiology, Cell Research, International Immunopharmacology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.